Antiemesis Conference Paper uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Vomiting

abstract

  • Chemotherapy-induced nausea and vomiting (emesis) can significantly affect a patient's quality of life, leading to poor adherence with further chemotherapy treatment. In addition, nausea and vomiting can result in other serious complications and deterioration of the patient's status. These guidelines explore the prevention, treatment, and management of various types of emesis experienced by cancer patients, such as breakthrough, radiation-induced, and anticipatory. The latest 2009 NCCN Guidelines include updated dosing recommendations for palonosetron and dexamethasone and the inclusion of the granisetron transdermal patch after FDA approval. © Journal of the National Comprehensive Cancer Network.

publication date

  • May 2009

Research

keywords

  • Conference Paper

Identity

Language

  • eng

PubMed ID

  • 19460282

Additional Document Info

start page

  • 572

end page

  • 95

volume

  • 7

number

  • 5